Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/SANOFI-4698/news/Sanofi-beginnt-mit-der-Dosierung-in-einer-Phase-2-Studie-von-SAR443820-DNL788-bei-Menschen-mit-Mul-42818357/?utm_source=whatsapp&utm_medium=social&utm_campaign=share